Exercise performance in thalassemia major: Correlation with cardiac iron burden

American Journal of Hematology

Volumn 88, Issue 3, 2013, Pages 193-197

  Sohn, Eugene Y ^a   Kato, Roberta ^a   Noetzli, Leila J ^a   Gera, Aakanksha ^a   Coates, Thomas ^a   Harmatz, Paul ^b   Keens, Thomas G ^a   Wood, John C ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b CHILDREN S HOSPITAL OAKLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; HEMOGLOBIN; IRON;

ADOLESCENT; ADULT; ANEMIA; ARTICLE; BREATHING RATE; CARDIOPULMONARY FUNCTION; CONGESTIVE HEART FAILURE; CORONARY FLOW RESERVE; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; EXERCISE; EXERCISE TEST; FEMALE; FERRITIN BLOOD LEVEL; HEART; HEART FUNCTION; HEART INDEX; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART RATE; HEART SIZE; HEART STROKE VOLUME; HEMOGLOBIN BLOOD LEVEL; HUMAN; IRON OVERLOAD; IRON STORAGE; LIVER; LUNG GAS EXCHANGE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVATIONAL STUDY; PANCREAS; PHLEBOTOMY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULSE PRESSURE; SEX DIFFERENCE; THALASSEMIA MAJOR; TREADMILL EXERCISE;

ADOLESCENT; ADULT; BETA-THALASSEMIA; BLOOD TRANSFUSION; EXERCISE; EXERCISE TEST; FEMALE; HEART; HEART RATE; HEMOGLOBINS; HUMANS; IRON; IRON OVERLOAD; LUNG; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OXYGEN CONSUMPTION; SEX FACTORS; STROKE VOLUME;

EID: 84874289356     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.23370     Document Type: Article

References (25)

1. Borgna-Pignatti C, Rugolotto S, De Stefano P, et al. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica 2004;89:1187-1193.
2. Modell B, Khan M, Darlison M. Survival in beta-thalassaemia major in the UK: data from the UK Thalassaemia Register. Lancet 2000;355:2051-2052.
3. Zurlo MG, De Stefano P, Borgna-Pignatti C, et al. Survival and causes of death in thalassaemia major. Lancet 1989;2:27-30.
4. Agostoni P, Cerino M, Palermo P, et al. Exercise capacity in patients with beta-thalassaemia intermedia. Br J Haematol 2005;131:278-281.
5. Villa MP, Rotili PL, Santamaria F, et al. Physical performance in patients with thalassemia before and after transfusion. Pediatr Pulmonol 1996;21:367-372.
6. Cooper DM, Mansell AL, Weiner MA, et al. Low lung capacity and hypoxemia in children with thalassemia major. Am Rev Respir Dis 1980;121:639-646.
7. Cracowski C, Wuyam B, Klein V, et al. Lung function and exercise capacity in thalassaemia major. Eur Respir J 1998;12:1130-1136.
8. El-Beshlawy A, El Accaoui R, Abd El-Sattar M, et al. Effect of L: carnitine on the physical fitness of thalassemic patients. Ann Hematol 2007;86:31-34.
9. Grant GP, Graziano JH, Seaman C, et al. Cardiorespiratory response to exercise in patients with thalassemia major. Am Rev Respir Dis 1987;136:92-97.
10. Marinov BI, Terziyski KV, Sapunarova KG, et al. Exercise performance in children with severe beta-thalassemia before and after transfusion. Folia Med (Plovdiv) 2008;50:48-54.
11. Nanas S, Vasileiadis I, Dimopoulos S, et al. New insights into the exercise intolerance of beta-thalassemia major patients. Scand J Med Sci Sports 2009;19:96-102.
12. Tai DY, Wang YT, Lou J, et al. Lungs in thalassaemia major patients receiving regular transfusion. Eur Respir J 1996;9:1389-1394.
13. Vasileiadis I, Roditis P, Dimopoulos S, et al. Impaired oxygen kinetics in beta-thalassaemia major patients. Acta Physiol (Oxf) 2009;196:357-363.
14. Physicians. ATSACCP. ATS/ACCP statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med 2003;167:211-277.
15. Wood JC, Enriquez C, Ghugre N, et al. MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood 2005;106:1460-1465.
16. Carpenter JP, He T, Kirk P, et al. On T2* Magnetic Resonance and Cardiac Iron. Circulation 2011;123:1519-1528.
17. Ghugre NR, Enriquez CM, Coates TD, et al. Improved R2* measurements in myocardial iron overload. J Magn Reson Imaging 2006;23:9-16.
18. Wood JC, Otto-Duessel M, Aguilar M, et al. Cardiac iron determines cardiac T2*, T2, and T1 in the gerbil model of iron cardiomyopathy. Circulation 2005;112:535-543.
19. Ghugre NR, Enriquez CM, Gonzalez I, et al. MRI detects myocardial iron in the human heart. Magn Reson Med 2006;56:681-686.
20. Noetzli LJ, Papudesi J, Coates TD, et al. Pancreatic iron loading predicts cardiac iron loading in thalassemia major. Blood 2009;114:4021-4026.
21. Kirk P, Roughton M, Porter JB, et al. Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major. JCMR 2009;11:O2.
22. Tocco F, Crisafulli A, Melis F, et al. Exercise capacity and cardiovascular changes in patients with beta-thalassaemia major. Clin Physiol Funct Imaging 2006;26:319-322.
23. Uurtuya S, Kotani K, Koibuchi H, et al. The relationship between serum C-reactive protein and daily physical activity in Japanese hypertensive patients. Clin Exp Hypertens 2010;32:517-522.
24. 2+ currents leading to bradycardia, altered electrical conduction, and atrial fibrillation. Circ Arrhythm Electrophysiol 2011;4:733-742.
25. Detterich J, Noetzli L, Dorey F, et al. Electrocardiographic consequences of cardiac iron overload in thalassemia major. Am J Hematol 2011;87:139-144.